Delivering the goods
By M.V. Greene
By now, it seems that just
about everybody has heard of or used a ride platform that ferries people or
brings food — like Uber and Lyft for ride-hailing or Uber Eats, Postmates, Door
Dash and Grubhub for food. It is a spiraling market segment that, according to
SpotnRides, is to leapfrog to $220 billion by 2025 from around $61 billion in
2018.
Enter a Dallas,
Texas-based startup called CourMed® and its founder and CEO Derrick L. Miles,
whose twist on the crowdsourcing delivery business model couldn’t be more
precise.
Like the ride companies,
CourMed employs the same highly intuitive enterprise software to facilitate
innovative delivery. Only with CourMed, the innovation is the delivery of
health care products.
“We use similar technology
to make the deliveries from point A to B. What makes us different is that we
don’t deliver people, and we don’t deliver food,” Miles said. “We decided to
focus on health care product delivery only.”
Working with community
pharmacies, medical distribution companies, physician groups, hospitals and
directly with consumers, CourMed provides concierge delivery to homes and
offices of just about anything with a medical bent — prescriptions, high-end
vitamins, over-the-counter supplements, natural remedies, eyewear, patient
specimens, immuno-nutrition drinks and personal protective equipment. And in a
world overwhelmed by the COVID-19 pandemic, CourMed will even deliver and
administer life-saving vaccines.
“Anything from a health
care perspective that you used to leave your house for, we are actually
bringing it to you now,” Miles said.
He is an entrepreneur and
inventor with big ideas and a burning desire to scale. Miles jumpstarted his
career in health care with a degree in medical technology from Bethune-Cookman
University before buttressing that foundation with advanced degrees from the
University of Alabama at Birmingham and certificates from the University of
Michigan and Stanford University.
Driving innovation in the
health care delivery space has become embedded in Miles’ personal and business
DNA. At 31, he was an interim CEO at a Texas hospital, and he has worked in key
roles as a hospital executive in operations and logistics, which provided the
road map for striking out on his own.
“I realized that health
care was not the most innovative space to come up with ideas to improve the
lives of others but improving the lives of others is what it is all about,” he
said.
Being “bum-rushed”
CourMed launched in
November 2018 at the Irving, Texas, headquarters of a mighty benefactor,
Vizient Inc., a health care group purchaser that provides solutions and
services to improve the delivery of high-value care. That spark led the company
to other high-level engagements, including a 2019 invitation to the highly
regarded ideaShare, an independent pharmacy conference put on by McKesson
Corp., a global behemoth in health care supply-chain solutions.
Miles said CourMed was the
only delivery platform to be invited. And, he recalled being “bum-rushed” with
attention after a McKesson executive mentioned the company from the stage.
“We got on their radar,
and everybody was asking about CourMed,” Miles said.
So far, CourMed is
operating its delivery platform through McKesson, AmerisourceBergen and
Cardinal Health’s pharmacy networks. But Miles is reaching for more and
believes he knows what it will take to get there. While delivery remains core
to the company, he sees CourMed morphing into something greater through an
all-consuming concierge health care experience that includes health care services
that can be administered in the comfort of your living room and enterprise
software for hospitals and other health care providers that allow them to own
the patient experience end-to-end.
“We consider ourselves to
be a health care solutions company. We can still do the delivery, but we can
bring new revenue and higher-margin services. Those are two impactful aspects
of CourMed today,” he said.
Investments from
trillion-dollar behemoths
Expanding beyond delivery
was embraced by Microsoft Corp., which asked him to join its Microsoft for
Startups program that is designed to help emerging companies build scale and
revenues. CourMed graduated from the Microsoft for Startups program earlier
this year and is now an official Microsoft Partner.
Recently, CourMed was
named the first company to receive access to capital from Microsoft’s $50
million Partner Growth Initiative. In 2020, CourMed also received funding
through the Google for Startups Black Founders Fund, an initiative that
provides cash awards between $50,000 and $100,000 for U.S. startups led by
African American owners as part of its commitment to racial equity.
“Three out of four
companies with a trillion-dollar market cap have provided access to capital,
piloting opportunities and suggestions for new verticals for CourMed,” Miles
said. “Google started as a search engine, and Microsoft started as office
productivity software. Both companies are much more today. CourMed started as a
prescription delivery service, but we are much more today.”
To learn more about
CourMed, visit courmed.com.